Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Jerry

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Research|April 1, 1993
p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitroM A Ozbun, D J Jerry, F S Kittrell, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 1, 1996
Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoliF E Jones, D J Jerry, B C Guarino, et al.
Cancer Research|July 15, 1993
Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor developmentD J Jerry, M A Ozbun, F S Kittrell, et al.
Biology of Reproduction|April 25, 2001
Effect of fibroblast donor cell age and cell cycle on development of bovine nuclear transfer embryos in vitroP Kasinathan, J G Knott, P N Moreira, et al.
Cell Death & Disease|March 2, 2013
MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transitionA J DeCastro, K A Dunphy, J Hutchinson, et al.
Oncogene|November 12, 1998
Delayed involution of the mammary epithelium in BALB/c-p53null miceD J Jerry, C Kuperwasser, S R Downing, et al.
Molecular Carcinogenesis|March 1, 1994
Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous miceD J Jerry, J S Butel, L A Donehower, et al.
The American Journal of Pathology|December 7, 2000
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndromeC Kuperwasser, G D Hurlbut, F S Kittrell, et al.
Oncogene|February 26, 2013
siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumorsM Böhringer, K Obermeier, N Griner, et al.
Oncogene|March 14, 2000
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor developmentD J Jerry, F S Kittrell, C Kuperwasser, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Research|April 1, 1993
p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitroM A Ozbun, D J Jerry, F S Kittrell, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 1, 1996
Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoliF E Jones, D J Jerry, B C Guarino, et al.
Cancer Research|July 15, 1993
Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor developmentD J Jerry, M A Ozbun, F S Kittrell, et al.
Biology of Reproduction|April 25, 2001
Effect of fibroblast donor cell age and cell cycle on development of bovine nuclear transfer embryos in vitroP Kasinathan, J G Knott, P N Moreira, et al.
Cell Death & Disease|March 2, 2013
MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transitionA J DeCastro, K A Dunphy, J Hutchinson, et al.
Oncogene|November 12, 1998
Delayed involution of the mammary epithelium in BALB/c-p53null miceD J Jerry, C Kuperwasser, S R Downing, et al.
Molecular Carcinogenesis|March 1, 1994
Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous miceD J Jerry, J S Butel, L A Donehower, et al.
The American Journal of Pathology|December 7, 2000
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndromeC Kuperwasser, G D Hurlbut, F S Kittrell, et al.
Oncogene|February 26, 2013
siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumorsM Böhringer, K Obermeier, N Griner, et al.
Oncogene|March 14, 2000
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor developmentD J Jerry, F S Kittrell, C Kuperwasser, et al.
Pageof 3